Details of the Drug

General Information of Drug (ID: DM15WU4)

Drug Name

MB-107

Indication

Disease Entry	ICD 11	Status	REF
Severe combined immunodeficiency	4A01.10	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Gene therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04887298) Study of Liposomal Annamycin for the Treatment of Subjects With Soft-Tissue Sarcomas (STS) With Pulmonary Metastases. U.S. National Institutes of Health.